Publicly Traded Biotech Firm 180 Life Sciences Plans Ethereum Treasury With Yield Generation Ambitions
Main Idea
180 Life Sciences rebrands as ETHZilla and launches a $425 million Ethereum treasury via a PIPE offering, aiming to generate 3-10% annual yield through on-chain strategies with Electric Capital.
Key Points
1. 180 Life Sciences has rebranded as ETHZilla and announced a $425 million PIPE offering priced at $2.65 per share, backed by over 60 institutional and crypto-native investors.
2. ETHZilla plans to generate 3-10% annual yield through innovative on-chain strategies, aiming to outperform traditional ETH staking returns.
3. The company's strategy involves reinvesting yield-generated cash flows to acquire more Ethereum, positioning itself as a dominant player in the Ethereum treasury sector.
4. ETHZilla's stock (ATNF) saw a 10% increase following the announcement, reflecting market confidence in its new strategy.
5. The company combines institutional capital with expert yield generation, leveraging Ethereum's financial ecosystem to enhance shareholder value.
Description
Are You Chasing New Coins? Catch the newest crypto opportunities. Be the first to buy, be the first to win! Click here to discover new altcoins! 180 Life Sciences
Latest News
- SEC Approval May Enhance Efficiency and Institutional Appeal of Bitcoin ETFs Through In-Kind Transactions2025-07-30 12:54:22
- Ethereum’s Decade of Innovation Sees Renewed Institutional Interest and ETF Momentum in 20252025-07-30 12:37:20
- Coinbase Partners With JP Morgan, Allowing Credit Card Purchases On Coinbase And Redeeming Chase Points For USDC.2025-07-30 12:36:03
- Volusia County’s Seizure of Bitcoin From Foreign Brokerage Faces Legal Scrutiny Over Procedural Issues2025-07-30 12:35:45
- Whale Moves 20,000 ETH from Binance, Transfers 16,000 ETH to Aave V3 – Mars Finance Update2025-07-30 12:34:05